These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 8629052

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. [Risk factors of intrahepatic cholangiocarcinoma: a case-control study].
    Zhou HB, Xu QR, Wang H, Zhou DX, Wang H, Wang Q, Zhou SS, Tu QQ, Sun ZQ, Ai L, Wu MC, Hu HP.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Dec; 17(12):935-9. PubMed ID: 20038337
    [Abstract] [Full Text] [Related]

  • 43. Serum protease inhibitors in opisthorchiasis, hepatoma, cholangiocarcinoma, and other liver diseases.
    Changbumrung S, Migasena P, Supawan V, Juttijudata P, Buavatana T.
    Southeast Asian J Trop Med Public Health; 1988 Jun; 19(2):299-305. PubMed ID: 2465579
    [Abstract] [Full Text] [Related]

  • 44. Etiology of hepatocellular carcinoma in Italian patients with and without cirrhosis.
    Chiesa R, Donato F, Tagger A, Favret M, Ribero ML, Nardi G, Gelatti U, Bucella E, Tomasi E, Portolani N, Bonetti M, Bettini L, Pelizzari G, Salmi A, Savio A, Garatti M, Callea F.
    Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):213-6. PubMed ID: 10698484
    [Abstract] [Full Text] [Related]

  • 45. TaqMan real-time PCR assay for specific detection of Opisthorchis viverrini DNA in Thai patients with hepatocellular carcinoma and cholangiocarcinoma.
    Suksumek N, Leelawat K, Leelawat S, Russell B, Lek-Uthai U.
    Exp Parasitol; 2008 Jun; 119(2):217-24. PubMed ID: 18329641
    [Abstract] [Full Text] [Related]

  • 46. Does the concentration of alpha 1-proteinase inhibitor reflect the transformation of liver cirrhosis to liver carcinoma?
    Dabrowska M, Mantur M, Panasiuk A, Prokopowicz J.
    Neoplasma; 1997 Jun; 44(5):305-7. PubMed ID: 9473790
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis.
    Kuper H, Ye W, Broomé U, Romelsjö A, Mucci LA, Ekbom A, Adami HO, Trichopoulos D, Nyrén O.
    Hepatology; 2001 Oct; 34(4 Pt 1):714-8. PubMed ID: 11584367
    [Abstract] [Full Text] [Related]

  • 49. [Liver cirrhosis caused by alpha-1-antitrypsin deficiency].
    Persić M, Prica M, Rajh-Gustincić M, Sepić A, Sabolić J.
    Acta Med Iugosl; 1989 Oct; 43(2):137-46. PubMed ID: 2787094
    [Abstract] [Full Text] [Related]

  • 50. [Epidemiology of primary and secondary liver cancers].
    Jepsen P, Kissmeyer-Nielsen P.
    Ugeskr Laeger; 2008 Apr 14; 170(16):1323-5. PubMed ID: 18433588
    [Abstract] [Full Text] [Related]

  • 51. Cirrhosis associated with homozygous alpha-1 antitrypsin deficiency in the adult: a case report.
    Chibbaro G, Bartoloni Saint Omer F, offtti A, Nucci A, Verdiani V.
    Ital J Gastroenterol; 1991 May 14; 23(4):216-8. PubMed ID: 1751819
    [Abstract] [Full Text] [Related]

  • 52. Increased risk of chronic liver failure in adults with heterozygous alpha1-antitrypsin deficiency.
    Graziadei IW, Joseph JJ, Wiesner RH, Therneau TM, Batts KP, Porayko MK.
    Hepatology; 1998 Oct 14; 28(4):1058-63. PubMed ID: 9755243
    [Abstract] [Full Text] [Related]

  • 53. [Hepatology 2008].
    Thimme R, Spangenberg HC, Blum HE.
    Dtsch Med Wochenschr; 2008 Jun 14; 133(25-26):1366-9. PubMed ID: 18553264
    [No Abstract] [Full Text] [Related]

  • 54. [Hepatic involvement in hereditary alpha-1-antitrypsin deficiency].
    Lachaux A, Dumortier J.
    Rev Mal Respir; 2014 Apr 14; 31(4):357-64. PubMed ID: 24750955
    [Abstract] [Full Text] [Related]

  • 55. Is heterozygous alpha-1-antitrypsin deficiency type PIZ a risk factor for primary liver carcinoma?
    Zhou H, Ortiz-Pallardó ME, Ko Y, Fischer HP.
    Cancer; 2000 Jun 15; 88(12):2668-76. PubMed ID: 10870048
    [Abstract] [Full Text] [Related]

  • 56. [alpha 1-Antitrypsin phenotypes in patients with chronic liver diseases].
    Pott G, Schneider M, van Husen N, von Bassewitz DB, Eberhardt G, Gerlach U.
    Z Gastroenterol; 1983 Jul 15; 21(7):318-23. PubMed ID: 6604375
    [Abstract] [Full Text] [Related]

  • 57. Preneoplastic conditions of the liver.
    Riegler JL.
    Semin Gastrointest Dis; 1996 Apr 15; 7(2):74-87. PubMed ID: 8705261
    [Abstract] [Full Text] [Related]

  • 58. Histological features of cirrhosis with hepatitis C virus for prediction of hepatocellular carcinoma development; a prospective study.
    Makino Y, Shiraki K, Sugimoto K, Ito T, Yamanaka T, Fujikawa K, Takase K, Nakano T.
    Anticancer Res; 2000 Apr 15; 20(5C):3709-15. PubMed ID: 11268443
    [Abstract] [Full Text] [Related]

  • 59. The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma.
    Chiba T, Matsuzaki Y, Abei M, Shoda J, Tanaka N, Osuga T, Aikawa T.
    Am J Gastroenterol; 1996 Jun 15; 91(6):1195-203. PubMed ID: 8651170
    [Abstract] [Full Text] [Related]

  • 60. Hepatocyte proliferation and risk of hepatocellular carcinoma in cirrhotic patients.
    Sangiovanni A, Colombo E, Radaelli F, Bortoli A, Bovo G, Casiraghi MA, Ceriani R, Roffi L, Redaelli A, Rossini A, Spinzi G, Minoli G.
    Am J Gastroenterol; 2001 May 15; 96(5):1575-80. PubMed ID: 11374702
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.